Prostate cancer-specific thermo-responsive polymer-coated iron oxide nanoparticles

Biomaterials

Volumn 34, Issue 14, 2013, Pages 3618-3625

  Wadajkar, Aniket S ^a,b   Menon, Jyothi U ^a,b   Tsai, Yuh Shyan ^c,d   Gore, Crystal ^c   Dobin, Timothy ^c   Gandee, Leah ^c   Kangasniemi, Kim ^c   Takahashi, Masaya ^c   Manandhar, Bikash ^e   Ahn, Jung Mo ^e   Hsieh, Jer Tsong ^c   Nguyen, Kytai T ^a,b  

^a University of Texas at Arlington   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Hyperthermia; Magnetic resonance imaging; Prostate cancer; Superparamagnetic iron oxide magnetic nanoparticles; Thermo responsive polymers

Indexed keywords

HUMAN DERMAL FIBROBLASTS; HYPERTHERMIA; LOWER CRITICAL SOLUTION TEMPERATURE; MAGNETIC CHARACTERIZATION; MAGNETIC NANO-PARTICLES; PROSTATE CANCERS; SUPERPARAMAGNETIC BEHAVIOR; THERMORESPONSIVE POLYMER;

ACRYLIC MONOMERS; BIOMATERIALS; CELLS; MAGNETIC RESONANCE IMAGING; NANOMAGNETICS; NANOPARTICLES; ORGANIC POLYMERS; SUPERPARAMAGNETISM; TUMORS; UROLOGY;

DISEASES;

IRON OXIDE; POLY(N ISOPROPYLACRYLAMIDE ACRYLAMIDE ALLYLAMINE) COATED IRON OXIDE; POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; IN VIVO STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; SKIN FIBROBLAST; SYNTHESIS;

ANIMALS; CELL LINE, TUMOR; FERRIC COMPOUNDS; HUMANS; HYPERTHERMIA, INDUCED; MALE; MICE; MICE, SCID; NANOPARTICLES; POLYMERS; PROSTATIC NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84875252048     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2013.01.062     Document Type: Article

References (31)

1. Bharali D.J., Mousa S.A. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise. Pharmacol Ther 2010, 128(2):324-335.
2. Raghavan D., Koczwara B., Javle M. Evolving strategies of cytotoxic chemotherapy for advanced prostate cancer. Eur J Cancer 1997, 33(4):566-574.
3. Graf N., Bielenberg D.R., Kolishetti N., Muus C., Banyard J., Farokhzad O.C., et al. α(V)β(3) integrin-targeted PLGA-PEG nanoparticles for enhanced anti-tumor efficacy of a Pt(IV) prodrug. ACS Nano 2012, 6(5):4530-4539.
4. Zhao D., Zhao X., Zu Y., Li J., Zhang Y., Jiang R., et al. Preparation, characterization, and in vitro targeted delivery of folate-decorated paclitaxel-loaded bovine serum albumin nanoparticles. Int J Nanomedicine 2010, 5:669-677.
5. Hsieh J.T., Zhou J., Gore C., Zimmern P. R11, a novel cell-permeable peptide, as an intravesical delivery vehicle. BJU Int 2011, 108(10):1666-1671.
6. Nakase I., Tadokoro A., Kawabata N., Takeuchi T., Katoh H., Hiramoto K., et al. Interaction of arginine-rich peptides with membrane-associated proteoglycans is crucial for induction of actin organization and macropinocytosis. Biochemistry 2007, 46(2):492-501.
7. Rothbard J.B., Jessop T.C., Lewis R.S., Murray B.A., Wender P.A. Role of membrane potential and hydrogen bonding in the mechanism of translocation of guanidinium-rich peptides into cells. J Am Chem Soc 2004, 126(31):9506-9507.
8. Zhou J., Fan J., Hsieh J.T. Inhibition of mitogen-elicited signal transduction and growth in prostate cancer with a small peptide derived from the functional domain of DOC-2/DAB2 delivered by a unique vehicle. Cancer Res 2006, 66(18):8954-8958.
9. Hao G., Zhou J., Guo Y., Long M.A., Anthony T., Stanfield J., et al. A cell permeable peptide analog as a potential-specific PET imaging probe for prostate cancer detection. Amino Acids 2011, 41(5):1093-1101.
10. Zhou J., Liu W., Pong R.C., Hao G., Sun X., Hsieh J.T. Analysis of oligo-arginine cell-permeable peptides uptake by prostate cells. Amino Acids 2012, 42(4):1253-1260.
11. Rahimi M., Kilaru S., Sleiman G.E., Saleh A., Rudkevich D., Nguyen K. Synthesis and characterization of thermo-sensitive nanoparticles for drug delivery applications. J Biomed Nanotechnol 2008, 4(4):482-490.
12. Rahimi M., Wadajkar A., Subramanian K., Yousef M., Cui W., Hsieh J.T., et al. In vitro evaluation of novel polymer-coated magnetic nanoparticles for controlled drug delivery. Nanomedicine 2010, 6(5):672-680.
13. Wadajkar A.S., Bhavsar Z., Ko C.Y., Koppolu B., Cui W., Tang L., et al. Multifunctional particles for melanoma-targeted drug delivery. Acta Biomater 2012, 8(8):2996-3004.
14. Wadajkar A.S., Kadapure T., Zhang Y., Cui W., Nguyen K.T., Yang J. Dual-imaging enabled cancer-targeting nanoparticles. Adv Health Mater 2012, 1(4):450-456.
15. Wu T., Hua M.Y., Chen J.P., Wei K.C., Jung S.M., Chang Y.J., et al. Effects of external magnetic field on biodistribution of nanoparticles: a histological study. J Magn Magn Mater 2007, 311(1):372-375.
16. Jain N., Wang Y., Jones S.K., Hawkett B.S., Warr G.G. Optimized steric stabilization of aqueous ferrofluids and magnetic nanoparticles. Langmuir 2010, 26(6):4465-4472.
17. Zeta potential analysis of nanoparticles 2012, NanoComposix. http://nanocomposix.com/sites/default/files/nanoComposix%2520Guidelines%2520for%2520Zeta%2520Potential%2520Analysis%2520of%2520Nanoparticles.pdf.
18. He F., Zhao D. Manipulating the size and dispersibility of zerovalent iron nanoparticles by use of carboxymethyl cellulose stabilizers. Environ Sci Technol 2007, 41(17):6216-6221.
19. Inoue H., Katayama K., Iwai K., Miura A., Masuhara H. Conformational relaxation dynamics of a poly(N-isopropylacrylamide) aqueous solution measured using the laser temperature jump transient grating method. Phys Chem Chem Phys 2012, 14(16):5620-5627.
20. Bao H., Chen Z., Kang L., Wu P., Liu J. Preparation of magnetic nanoparticles modified by amphiphilic copolymers. Mater Lett 2006, 60:2167-2170.
21. Ramirez L.P., Landfester K. Magnetic polystyrene nanoparticles with a high magnetite content obtained by miniemulsion processes. Macromol Chem Phys 2003, 204(1):22-31.
22. Pouponneau P., Leroux J., Martel S. Magnetic nanoparticles encapsulated into biodegradable microparticles steered with an upgraded magnetic resonance imaging system for tumor chemoembolization. Biomaterials 2009, 30:6327-6332.
23. 4 magnetic nanoparticles modified with biocompatible copolymers. Int J Nanomedicine 2012, 7:511-526.
24. Naha P.C., Bhattacharya K., Tenuta T., Dawson K.A., Lynch I., Gracia A., et al. Intracellular localisation, geno- and cytotoxic response of polyN-isopropylacrylamide (PNIPAM) nanoparticles to human keratinocyte (HaCaT) and colon cells (SW 480). Toxicol Lett 2010, 198(2):134-143.
25. Vihola H., Laukkanen A., Valtola L., Tenhu H., Hirvonen J. Cytotoxicity of thermosensitive polymers poly(N-isopropylacrylamide), poly(N-vinylcaprolactam) and amphiphilically modified poly(N-vinylcaprolactam). Biomaterials 2005, 26(16):3055-3064.
26. Noguchi H., Matsushita M., Okitsu T., Moriwaki A., Tomizawa K., Kang S., et al. A new cell-permeable peptide allows successful allogeneic islet transplantation in mice. Nat Med 2004, 10(3):305-309.
27. Tzeng S.Y., Guerrero-Cázares H., Martinez E.E., Sunshine J.C., Quiñones-Hinojosa A., Green J.J. Non-viral gene delivery nanoparticles based on poly(β-amino esters) for treatment of glioblastoma. Biomaterials 2011, 32(23):5402-5410.
28. Patel R.H., Wadajkar A.S., Patel N.L., Kavuri V.C., Nguyen K.T., Liu H. Multifunctionality of indocyanine green-loaded biodegradable nanoparticles for enhanced optical imaging and hyperthermia intervention of cancer. J Biomed Opt 2012, 17(4):046003.
29. Wang A.Z., Bagalkot V., Vasilliou C.C., Gu F., Alexis F., Zhang L., et al. Superparamagnetic iron oxide nanoparticle-aptamer bioconjugates for combined prostate cancer imaging and therapy. ChemMedChem 2008, 3(9):1311-1315.
30. Ghosh D., Lee Y., Thomas S., Kohli A.G., Yun D.S., Belcher A.M., et al. M13-templated magnetic nanoparticles for targeted in vivo imaging of prostate cancer. Nat Nanotechnol 2012, 7(10):677-682.
31. Foster B.A., Kaplan P.J., Greenberg N.M. Peptide growth factors and prostate cancer: new models, new opportunities. Cancer Metastasis Rev 1998, 17(4):317-324.